“Don’t flog the heart!” — development of specific drug therapies for heart failure
Authors:
- Helge H. RasmussenHRHelge H. Rasmussen
- Gemma FigtreeGFGemma Figtree
Open Access
- 1 December 2007
- journal article
- Published by Elsevier in Critical Care and Resuscitation
- Vol. 9 (4) , 364-369
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- The nitric oxide donor sodium nitroprusside stimulates the Na+–K+ pump in isolated rabbit cardiac myocytesThe Journal of Physiology, 2005
- Adverse Mortality Effect of Central Sympathetic Inhibition with Sustained-Release Moxonidine in Patients with Heart Failure (MOXCON)European Journal of Heart Failure, 2003
- [Na+]i handling in the failing human heartCardiovascular Research, 2003
- Intracellular Na in animal models of hypertrophy and heart failure: contractile function and arrhythmogenesisCardiovascular Research, 2003
- Intracellular Na+ regulation in cardiac myocytesCardiovascular Research, 2003
- Nitric oxide and myocardial function in heart failure: friend or foe?Heart, 2002
- β3-Adrenoceptor agonists: potential, pitfalls and progressEuropean Journal of Pharmacology, 2002
- Heart failure 99 — the Moxcon storyInternational Journal of Cardiology, 1999
- Angiotensin-converting enzyme inhibitors regulate the Na(+)-K+ pump via effects on angiotensin metabolismAmerican Journal of Physiology-Cell Physiology, 1996
- Angiotensin-converting enzyme inhibition, intracellular Na+, and Na(+)-K+ pumping in cardiac myocytesAmerican Journal of Physiology-Cell Physiology, 1995